All Stories

  1. Citicoline in stroke and TBI clinical trials
  2. Erratum to: Anti-proliferative Effects of Tricyclodecan-9-yl-xanthogenate (D609) Involve Ceramide and Cell Cycle Inhibition
  3. Anti-proliferative Effects of Tricyclodecan-9-yl-xanthogenate (D609) Involve Ceramide and Cell Cycle Inhibition
  4. Distinction between phosphatidylcholine (PC)–specific phospholipase C (PC–PLC) and phosphatidylinositol (PI)–specific phospolipase C (PI–PLC) needs clarification
  5. Tricyclodecan-9-yl-Xanthogenate (D609) Mechanism of Actions: A Mini-Review of Literature
  6. Protection by D609 Through Cell-Cycle Regulation After Stroke
  7. Lipid Oxidation and Peroxidation in CNS Health and Disease: From Molecular Mechanisms to Therapeutic Opportunities
  8. Lipid Alterations in Transient Forebrain Ischemia
  9. Challenges in stroke treatment beyond tPA; clinically relevant experimental treatments
  10. Integration of cytokine biology and lipid metabolism in stroke
  11. Role of lipids in brain injury and diseases
  12. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen–glucose deprivation in PC12 cells
  13. Lipids and lipidomics in brain injury and diseases
  14. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia
  15. Lipids and Lipidomics in Brain Injury and Diseases
  16. CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke
  17. Cytidine 5?-Diphosphocholine (CDP-Choline) in Stroke and Other CNS Disorders
  18. Cytidine-5?-diphosphocholine affects CTP-phosphocholine cytidylyltransferase and lyso-phosphatidylcholine after transient brain ischemia
  19. Phospholipase A 2 , Hydroxyl Radicals, and Lipid Peroxidation in Transient Cerebral Ischemia
  20. Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia
  21. Loss of cardiolipin and mitochondria during programmed neuronal death: evidence of a role for lipid peroxidation and autophagy
  22. Ornithine Decarboxylase Activity and Edema Formation in Cerebral Ischemia of Conscious Gerbils
  23. Citicoline mechanisms and clinical efficacy in cerebral ischemia
  24. Polyamines and central nervous system injury: spermine and spermidine decrease following transient focal cerebral ischemia in spontaneously hypertensive rats
  25. Effects of Citicoline on Phospholipid and Glutathione Levels in Transient Cerebral Ischemia
  26. 817 Polyamine Interconversion Pathway in Transient Focal Cerebral Ischemia
  27. 817 Polyamine Interconversion Pathway in Transient Focal Cerebral Ischemia
  28. Does CDP-choline modulate phospholipase activities after transient forebrain ischemia?
  29. Up-regulation of the peripheral-type benzodiazepine receptor expression and [3H]PK11195 binding in gerbil hippocampus after transient forebrain ischemia
  30. Glial glutamate transporter GLT-1 down-regulation precedes delayed neuronal death in gerbil hippocampus following transient global cerebral ischemia
  31. Neuroprotective effects of citicoline on brain edema and blood—brain barrier breakdown after traumatic brain injury
  32. Elevated N1-Acetylspermidine Levels in Gerbil and Rat Brains After CNS Injury
  33. CDP‐choline: Neuroprotection in transient forebrain ischemia of gerbils
  34. CDP-choline: Neuroprotection in transient forebrain ischemia of gerbils
  35. Contribution of polyamine oxidase to brain injury after trauma
  36. Effects of MDL 72527, a Specific Inhibitor of Polyamine Oxidase, on Brain Edema, Ischemic Injury Volume, and Tissue Polyamine Levels in Rats After Temporary Middle Cerebral After Occlusion
  37. Simultaneous assay of ornithine decarboxylase and polyamines after central nervous system injury in gerbil and rat
  38. Increased ornithine decarboxylase activity and protein level in the cortex following traumatic brain injury in rats
  39. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia
  40. The biphasic opening of the blood–brain barrier in the cortex and hippocampus after traumatic brain injury in rats
  41. Beneficial effects of S-adenosyl-l-methionine on blood–brain barrier breakdown and neuronal survival after transient cerebral ischemia in gerbils
  42. Protective Effects of Ifenprodil on Ischemic Injury Size, Blood-Brain Barrier Breakdown, and Edema Formation in Focal Cerebral Ischemia
  43. Regional brain polyamine levels in permanent focal cerebral ischemia
  44. Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia
  45. Delayed hyperglycemia and intracellular acidosis during focal cerebral ischemia in cats
  46. Enhanced accumulation of free fatty acids in experimental focal cerebral ischemia
  47. Effect of Difluoromethylornithine Treatment on Regional Ornithine Decarboxylase Activity and Edema Formation after Experimental Brain Injury
  48. Regional Activity of Ornithine Decarboxylase and Edema Formation after Traumatic Brain Injury
  49. Cholesterol oxidation reduces Ca2+ + Mg2+-ATPase activity, interdigitation, and increases fluidity of brain synaptic plasma membranes
  50. Nitrogen isotope effects on acetylcholinesterase-catalyzed hydrolysis of o-nitroacetanilide
  51. Cholesterol Exchange and Lateral Cholesterol Pools in Synaptosomal Membranes of Pair-Fed Control and Chronic Ethanol-Treated Mice
  52. Membrane Cholesterol and Ethanol: Domains, Kinetics, and Protein Function
  53. Simple general acid-base catalysis of physiological acetylcholinesterase reactions
  54. Specific Action of Ethanol on Lateral and Vertical Membrane Lipid Domains
  55. Crystal and molecular structures of alkali- and alkaline-earth-metal complexes of N,N-dimethylformamide
  56. An ab initio molecular orbital study of the interactions and reactions of the hydroperoxyl radical, HO2, and related species
  57. Interaction of α-tocopherol with diphenylpicryl hydrazyl a means to determine the polarity of the environment around α-tocopherol and its binding with lipids
  58. Altered Lipid Metabolism in Brain Injury and Disorders